Related Experiment Video
Updated: Nov 2, 2025
10:10
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
8.9K
Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges.
Yiyin Gao1, Guijie Wu1, Ying Xu1
1Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Cell Transplantation
|June 9, 2021
Summary
Stem cell therapy shows promise for treating Asherman syndrome (AS) by regenerating the endometrium. This review explores resident and exogenous stem cells, including bone marrow-derived stem cells (BMDSCs), for endometrial repair.
Area of Science:
- Reproductive Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Asherman syndrome (AS) impairs endometrial regeneration, negatively impacting reproductive health and fertility.
- Current treatments for AS have limitations in fully restoring endometrial function.
- Stem cell-based therapies offer a promising avenue for endometrial repair and reconstruction.
Purpose of the Study:
- To review resident endometrial stem cells (EnSCs) and their biomarkers.
- To examine the application of various exogenous stem cell sources in treating AS.
- To discuss advancements in stem cell therapy for AS, including biomaterials and exosomes.
Main Methods:
- Literature review of studies on endometrial stem cells and stem cell applications in Asherman syndrome.
- Analysis of features and biomarkers of four types of resident EnSCs.
- Evaluation of applications of four exogenous stem cell sources (e.g., bone marrow, menstrual blood, umbilical cord, amniotic membrane) in AS.
Main Results:
- Identified key features and specific biomarkers for resident endometrial stem cells.
- Highlighted the potential of bone marrow-derived stem cells (BMDSCs) for endometrial repair.
- Discussed the therapeutic potential of stem cells from menstrual blood, umbilical cord, and amniotic membrane for AS treatment.
Conclusions:
- Stem cell therapies, utilizing both resident and exogenous sources, hold significant potential for treating Asherman syndrome.
- Further research into biomaterials and exosomes can enhance the efficacy of stem cell-based treatments for endometrial regeneration.
- Stem cell approaches may offer a novel strategy to restore fertility in patients with AS.
Keywords:
asherman syndromebone marrow-derived stem cellsendometrial regenerationendometrial stem cellsstem cell transplantationMore Related Videos
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
6.3K
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
7.1K
Related Concept Videos
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
00:57Embryonic Stem Cells
4.1K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.1K
00:58Embryonic Stem Cells
29.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.5K
01:06Induced Pluripotent Stem Cells
4.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.7K
01:21Stem Cell Therapy for Tissue Regeneration
4.3K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
01:17Stem Cell Culture
5.7K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.7K